0 Комментарии
0 Поделились
87 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Biologics Virus Filtration Market: Insights and Competitive Analysis"Comprehensive Outlook on Executive Summary Biologics Virus Filtration Market Size and Share CAGR Value Global biologics virus filtration market size was valued at USD 2,316.72 million in 2024 and is projected to reach USD 5,082.85 million by 2032, with a CAGR of 10.32% during the forecast period of 2025 to 2032 Taking up Biologics Virus Filtration Market research report is...0 Комментарии 0 Поделились 481 Просмотры 0 предпросмотр
-
Customized Wound Care Biologics Market Overview: Demand Trends, Revenue Analysis, and Investment Opportunities"Latest Insights on Executive Summary Customized Wound Care Biologics Market Share and Size The global customized wound care biologics market size was valued at USD 2.80 billion in 2024 and is expected to reach USD 5.91 billion by 2032, at a CAGR of 9.80% during the forecast period The market insights gained through this keyword market research analysis...0 Комментарии 0 Поделились 110 Просмотры 0 предпросмотр
-
Customized Wound Care Biologics Market: Clinical Innovation Trends and Strategic Growth Forecast 2032"Executive Summary Customized Wound Care Biologics Market: Growth Trends and Share Breakdown The global customized wound care biologics market size was valued at USD 2.80 billion in 2024 and is expected to reach USD 5.91 billion by 2032, at a CAGR of 9.80% during the forecast period Being a premium market research report, Customized Wound Care Biologics...0 Комментарии 0 Поделились 366 Просмотры 0 предпросмотр
-
Europe Adalimumab Market Advances as Biologics Adoption and Chronic Disease Incidence Increase"Executive Summary Europe Adalimumab Market: Share, Size & Strategic Insights CAGR Value Data Bridge Market Research analyses that the market is growing with a CAGR of 16.2% in the forecast period of 2022 to 2029 and is expected to reach USD 10,337.79 million by 2029 from USD 3,485.94 million in 2021. Europe Adalimumab Market report is structured with the best and advanced tools of...0 Комментарии 0 Поделились 253 Просмотры 0 предпросмотр
-
Integrated Care: Addressing the Global Rise of Obesity and Diabetes via Digital Health and Biologics"In-Depth Study on Executive Summary Cardiometabolic Diseases Market Size and Share The global cardiometabolic diseases market size was valued at USD 192.9 billion in 2024 and is expected to reach USD 305.14 billion by 2032, at a CAGR of 5.90% during the forecast period All statistical and numerical data is interpreted with the use of established and...0 Комментарии 0 Поделились 122 Просмотры 0 предпросмотр
-
Multiple Sclerosis Therapies Market Expands with Innovative Drug Development and Biologics"Latest Insights on Executive Summary Multiple Sclerosis Therapies Market Share and Size CAGR Value Data Bridge Market Research analyses that the multiple sclerosis therapies market is expected to reach USD 38.33 million by 2030, which is USD 25.75 million in 2022, and is expected to undergo a CAGR of 5.10% during the forecast period 2023 to 2030. Multiple Sclerosis Therapies...0 Комментарии 0 Поделились 506 Просмотры 0 предпросмотр
-
North America Adalimumab Market Growth Outlook Supported by Biologics Demand & Autoimmune Treatment Expansion"In-Depth Study on Executive Summary North America Adalimumab Market Size and Share CAGR Value Data Bridge Market Research analyses a growth rate in the adalimumab market in the forecast period 2023-2030. The expected CAGR of adalimumab market is tend to be around 5.40 % in the mentioned forecast period. The market was valued at USD 16,879.8 million in 2022, and it would grow upto...0 Комментарии 0 Поделились 160 Просмотры 0 предпросмотр
-
Precision Immunology: New Biologics and Targeted Therapies Redefining the 2026 Lupus Care Path"Global Executive Summary Systemic Lupus Erythematosus Market Market: Size, Share, and Forecast The global systemic lupus erythematosus market size was valued at USD 949.20 million in 2025 and is expected to reach USD 1,699.18 million by 2033, at a CAGR of 7.55% during the forecast period The complete Systemic Lupus Erythematosus Market Market report is spread across a number of pages, list of...0 Комментарии 0 Поделились 106 Просмотры 0 предпросмотр
-
Precision Immunology: New Biologics and Targeted Therapies Redefining the 2026 Lupus Care Path"Global Executive Summary Systemic Lupus Erythematosus Market Market: Size, Share, and Forecast The global systemic lupus erythematosus market size was valued at USD 949.20 million in 2025 and is expected to reach USD 1,699.18 million by 2033, at a CAGR of 7.55% during the forecast period The complete Systemic Lupus Erythematosus Market Market report is spread across a number of pages, list of...0 Комментарии 0 Поделились 94 Просмотры 0 предпросмотр
-
Retinal Biologics Market Opportunity, Demand, recent trends, Major Driving Factors and Business Growth Strategies 2033The Retinal Biologics Market research report lays emphasis on primary as well as secondary drivers, leading market segments, market share, regional analysis, and possible sales volume. It gives a detailed explanation on what the market definition, applications, classifications, market trends, and engagements are for a healthcare industry. Further, it delves into a comprehensive market overview...0 Комментарии 0 Поделились 187 Просмотры 0 предпросмотр
-
Retinal Biologics Market to Reach USD 43.98 Billion by 2033, Growing at 6.75% CAGRRetinal Biologics Market Overview The global retinal biologics market size was valued at USD 24.43 billion in 2024 and is projected to grow from USD 26.08 billion in 2025 to USD 43.98 billion by 2033, growing at a CAGR of 6.75% during the forecast period (2025-2033). Download Exclusive Research Report PDF Sample: (Including...0 Комментарии 0 Поделились 519 Просмотры 0 предпросмотр
-
CNS Therapeutics Market: Investment Opportunities and R&D StrategiesThe Future of CNS Therapeutics: Innovation, AI, and Personalized Medicine CNS Therapeutics Market Overview 2025–2033 The Global Central Nervous System (CNS) Therapeutics Market is undergoing a significant transformation as neuroscience, biotechnology, and digital innovation converge to address complex neurological and psychiatric disorders. Valued at USD 123.7...0 Комментарии 0 Поделились 334 Просмотры 0 предпросмотр
-
Global Health Preparedness Strengthens the Vaccine Production MarketIn-Depth Study on Executive Summary Vaccine Production Market Size and Share CAGR Value The global vaccine production market size was valued at USD 54.77 billion in 2024 and is expected to reach USD 95.88 billion by 2032, at a CAGR of7.25% during the forecast period Vaccine Production Market research report contains a key data about the market, emerging trends, product usage,...0 Комментарии 0 Поделились 438 Просмотры 0 предпросмотр
-
Latin America Hemodynamic Monitoring System Market Insights: Growth, Share, Value, Size, and Trends"Market Trends Shaping Executive Summary Latin America Hemodynamic Monitoring System Market Size and Share Data Bridge Market Research analyses that the Latin America hemodynamic monitoring systems market which was USD 108.12 billion in 2022, would rocket up to USD 139.98 billion by 2030, and is expected to undergo a CAGR of 5.3% during the forecast period from 2023 to 2030. ...0 Комментарии 0 Поделились 7Кб Просмотры 0 предпросмотр
-
Multiple Sclerosis Drugs Market to Reach $36.6 Billion by 2033, Growing at 3.7% CAGRMarket Overview The global multiple sclerosis drugs market size was valued at USD 26.39 billion in 2024 and is projected to reach from USD 27.37 billion in 2025 to USD 36.6 billion by 2033, growing at a CAGR of 3.7% during the forecast period (2025-2033). The global Multiple Sclerosis Drugs market is witnessing swift transformation driven by new consumer...0 Комментарии 0 Поделились 504 Просмотры 0 предпросмотр
-
North America Anemia Drugs Market Set to Reach USD 5.9 Billion by 2032 Amid Rising CKD and Cancer CasesAccording to a new report from Intel Market Research, the North America Anemia Drugs Market was valued at USD 4,200 million in 2024 and is projected to grow from USD 4,410 million in 2025 to reach USD 5,900 million by 2032, growing at a CAGR of approximately 4.3% during the forecast period (2025–2032). This steady expansion is driven by the high and growing prevalence of chronic kidney...0 Комментарии 0 Поделились 39 Просмотры 0 предпросмотр
-
Psoriatic Arthritis Treatment Market to Grow at a CAGR of 7.8% Through 2032According to a new report published by Introspective Market Research, Psoriatic Arthritis Treatment Market by Drug Class (Biologics, DMARDs, NSAIDs, Others), Route of Administration (Oral, Injectable, Topical), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), The Global Psoriatic Arthritis Treatment Market Size Was Valued at USD 11.4 Billion...0 Комментарии 0 Поделились 264 Просмотры 0 предпросмотр
-
Romiplostim Market, Romiplostim Market Size, Romiplostim Market Forecast 2034, Thrombopoietin Receptor Agonist Market, Immune Thrombocytopenia Treatment Market, Nplate Drug Market, Biologics Market, Hematology Drug Market, ITP Therapeutics Market, PharmaceAccording to a new report from Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.75 billion by 2034, growing at a steady CAGR of 7.2% during the forecast period (2026-2034). This growth trajectory reflects the rising global burden of chronic immune thrombocytopenia (ITP) and increasing adoption of targeted biologic...0 Комментарии 0 Поделились 80 Просмотры 0 предпросмотр
Расширенные страницы
English
Kiswahili
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
